US Stock Insider Trading | Zai Lab disclosed three insider transactions on March 12

K-LinePoet · 2026-04-08T10:56:42+00:00

On March 12, 2026, Zai Lab (ZLAB) disclosed three insider trading transactions. Director Du Ying bought 261.1k shares on March 11, 2026.【Recent Insider Trading】| Disclosure Date | Position | Name | Transaction Date | Buy/Sell | Quantity | Price per Share/USD | Total Amount/USD || --- | --- | --- | --- | --- | --- | --- | --- || March 12, 2026 | Director | Du Ying | March 11, 2026 | Sell | 1,067 | 19.08 | $20.4k || March 12, 2026 | Director | Du Ying |

K-LinePoet

2026-04-08 10:56:42

On March 12, 2026, ZaiDing Pharmaceutical (ZLAB) disclosed three transactions by company insiders.

Director Du Ying purchased 261.1k shares on March 11, 2026.

[Recent Insider Transactions]

Disclosure Date	Position	Name	Trade Date	Buy/Sell	Quantity	Price per Share/US$	Total Amount/US$
March 12, 2026	Director	Du Ying	March 11, 2026	Sell	1067	19.08	20.4k
March 12, 2026	Director	Du Ying	March 10, 2026	Buy	261.1k	1.74	454.3k
March 12, 2026	Director	Du Ying	March 10, 2026	Sell	116.9k	19.41	2.27M
March 10, 2026	Director	Du Ying	March 9, 2026	Buy	100k	1.74	174k
March 10, 2026	Director	Du Ying	March 9, 2026	Sell	50k	19.03	951.5k
March 10, 2026	Director	Du Ying	March 6, 2026	Sell	50k	19.42	970.9k
March 6, 2026	Director	Du Ying	March 4, 2026	Sell	35.7k	19.32	689.8k
March 6, 2026	Director	Du Ying	March 4, 2026	Sell	14.3k	18.78	268.3k
March 6, 2026	Director	Du Ying	March 5, 2026	Buy	100k	1.74	174k
March 6, 2026	Director	Du Ying	March 5, 2026	Sell	50k	19.22	961.1k

[Company Profile]

ZaiDing Pharmaceutical Co., Ltd. is a holding company primarily engaged in biopharmaceuticals. The company is committed to addressing unmet medical needs in the fields of oncology, autoimmune diseases, infectious diseases, and diseases of the central nervous system through the discovery, development, and commercialization of its products. The company has a range of patent-eligible candidate drugs spanning from the discovery stage to the later stages of clinical programs. These include “ZelE,” “OPTUNE,” “QingLe,” “NewZaiLe,” “WeiWeiKa,” and others.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.